RegeneRx Awarded $3 Million Grant From NIH

RegeneRx Biopharmaceuticals announced Thursday that it has been awarded a $3 million grant from the NIH’s National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352 … for patients who have suffered an acute myocardial infarction.
Forbes